Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 10, 2025
Symeres, a global Contract Research, Development and Manufacturing Organization (CRDMO), announced the acquisition of DGr Pharma, a drug development-focused consultancy, to expand its integrated early-stage drug development services and accelerate ...
read more
Discovery Life Sciences™ has acquired Targos Molecular Pathology GmbH, Germany, one of the largest molecular pathology laboratories in Europe.
read more
Thursday, January 12, 2023
Eurofins CDMO Alphora Inc. announced the relocation and expansion of its API development laboratories from 2395 Speakman Drive to its new, owned facility at 2070 Hadwen Road, located within the Sheridan Research Park in Mississauga, Ontario, Canada.
read more
Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions (Upperton) has expanded its oral dosage form capabilities at its newly built headquarters in Nottingham, UK.
read more
Thursday, August 24, 2017
Ajinomoto Althea, Inc. (“Althea”), a leading service provider of biopharmaceutical contract development and manufacturing drug programs, announces the installation and launch of a new high-performance sterile vial filling line.
read more
Thursday, September 27, 2018
Brammer Bio announces that a three-year, $200 million investment program is on track to establish over 30 suites for clinical and commercial viral vector supply for a broad pipeline of advanced gene therapies and gene-modified cell therapies.
read more
Thursday, December 03, 2015
BioDelivery Sciences International has appointed Joseph (Jody) M. Lockhart as Vice President of Manufacturing and Supply Chain.
read more
Friday, September 14, 2018
Natera announced an agreement with Bristol-Myers Squibb to use Natera's Signatera custom circulating tumor DNA assay in a Phase 2 study in the adjuvant non-small cell lung cancer setting.
read more
Wednesday, January 20, 2021
Recipharm and Enzymatica have signed a broadened contract for the manufacture of ColdZyme.
read more
Wednesday, October 26, 2022
Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, announced its participation in the GENEGUT project to develop an innovative functional capsule-based delivery solution for therapies targeting ...
read more
Patheon reported financial results for the quarter ended April 30, 2017.
read more
Thursday, October 26, 2017
Achieve Life Sciences has entered into an exclusive supply agreement with Sopharma AD for the manufacture of cytisine API and finished tablets.
read more
Monday, September 12, 2022
AiCure, an artificial intelligence (AI) and advanced data analytics has announced the launch of its clinical site services offering. The new program provides sites with end-to-end, customized support and monitoring of metrics related to adherence, ...
read more
Tuesday, January 13, 2026
IMA Life announced its support of Sharp Sterile Manufacturing as part of its recent $28 million expansion of the Lee, Massachusetts facility. This strategic investment includes the installation of a fully automated IMA Life isolated filling line for ...
read more
Monday, November 03, 2025
The winners of this year’s CPHI Pharma Awards 2025 were recently announced and celebrate outstanding achievements across pharmaceutical innovation, leadership, manufacturing, sustainability, and women in pharma.
read more